医学
遗传性血管水肿
血管性水肿
梅德林
重症监护医学
皮肤病科
儿科
政治学
法学
作者
John Anderson,Daniel Soteres,Raffi Tachdjian,Jennifer M. Mellor,Lucy Earl,Hannah Connolly,Kieran Wynne-Cattanach,Kellyn M. Moran,Krystal Sing,Bob G. Schultz,Salomé Juethner
标识
DOI:10.2500/aap.2024.45.240046
摘要
Hereditary angioedema (HAE) is a rare genetic disorder characterized by painful, debilitating, and potentiallyfatal swelling attacks. Lanadelumab is approved as long-term prophylaxis (LTP) in patients with HAE. However, realworld data on LTP use in patients with HAE are limited.
科研通智能强力驱动
Strongly Powered by AbleSci AI